Literature DB >> 24759836

Induction of pluripotency in human somatic cells via a transient state resembling primitive streak-like mesendoderm.

Kazutoshi Takahashi1, Koji Tanabe1, Mari Ohnuki2, Megumi Narita2, Aki Sasaki2, Masamichi Yamamoto3, Michiko Nakamura2, Kenta Sutou2, Kenji Osafune2, Shinya Yamanaka4.   

Abstract

During mammalian embryonic development, the primitive streak initiates the differentiation of pluripotent epiblast cells into germ layers. Pluripotency can be reacquired in committed somatic cells using a combination of a handful of transcription factors, such as OCT3/4, SOX2, KLF4 and c-MYC (hereafter referred to as OSKM), albeit with low efficiency. Here we show that during OSKM-induced reprogramming towards pluripotency in human cells, intermediate cells transiently show gene expression profiles resembling mesendoderm, which is a major component of the primitive streak. Based on these findings, we discover that forkhead box H1 (FOXH1), a transcription factor required for anterior primitive streak specification during early development, significantly enhances the reprogramming efficiency of human fibroblasts by promoting their maturation, including mesenchymal to epithelial transition and the activation of late pluripotency markers. These results demonstrate that during the reprogramming process, human somatic cells go through a transient state that resembles mesendoderm.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24759836     DOI: 10.1038/ncomms4678

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  58 in total

Review 1.  Present and future challenges of induced pluripotent stem cells.

Authors:  Mari Ohnuki; Kazutoshi Takahashi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

2.  The XEN of reprogramming.

Authors:  Ergin Beyret; Juan Carlos Izpisua Belmonte
Journal:  Cell Res       Date:  2016-01-22       Impact factor: 25.617

3.  A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1.

Authors:  Evangelia Loizou; Ana Banito; Geulah Livshits; Yu-Jui Ho; Richard P Koche; Francisco J Sánchez-Rivera; Allison Mayle; Chi-Chao Chen; Savvas Kinalis; Frederik O Bagger; Edward R Kastenhuber; Benjamin H Durham; Scott W Lowe
Journal:  Cancer Discov       Date:  2019-05-08       Impact factor: 39.397

4.  Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts.

Authors:  Jordan E Pomeroy; Shelley R Hough; Kathryn C Davidson; Alex M Quaas; Jordan A Rees; Martin F Pera
Journal:  Stem Cells Transl Med       Date:  2016-05-09       Impact factor: 6.940

5.  Nascent Induced Pluripotent Stem Cells Efficiently Generate Entirely iPSC-Derived Mice while Expressing Differentiation-Associated Genes.

Authors:  Bhishma Amlani; Yiyuan Liu; Taotao Chen; Ly-Sha Ee; Peter Lopez; Adriana Heguy; Effie Apostolou; Sang Yong Kim; Matthias Stadtfeld
Journal:  Cell Rep       Date:  2018-01-28       Impact factor: 9.423

Review 6.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

7.  Dual optical recordings for action potentials and calcium handling in induced pluripotent stem cell models of cardiac arrhythmias using genetically encoded fluorescent indicators.

Authors:  LouJin Song; Daniel W Awari; Elizabeth Y Han; Eugenia Uche-Anya; Seon-Hye E Park; Yoko A Yabe; Wendy K Chung; Masayuki Yazawa
Journal:  Stem Cells Transl Med       Date:  2015-03-13       Impact factor: 6.940

8.  Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential.

Authors:  Mari Ohnuki; Koji Tanabe; Kenta Sutou; Ito Teramoto; Yuka Sawamura; Megumi Narita; Michiko Nakamura; Yumie Tokunaga; Masahiro Nakamura; Akira Watanabe; Shinya Yamanaka; Kazutoshi Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-05       Impact factor: 11.205

9.  AP-1 activity is a major barrier of human somatic cell reprogramming.

Authors:  Yuting Liu; Jiangping He; Ruhai Chen; He Liu; Jocelyn Chen; Yujian Liu; Bo Wang; Lin Guo; Duanqing Pei; Jie Wang; Jing Liu; Jiekai Chen
Journal:  Cell Mol Life Sci       Date:  2021-06-28       Impact factor: 9.261

Review 10.  Application of stem cell-derived retinal pigmented epithelium in retinal degenerative diseases: present and future.

Authors:  Mingyue Luo; Youxin Chen
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.